Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles, mumps, rubella and varicella vaccine
- Development stage
- Preclinical
- Lead developer
- Sinopharm
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
The MMRV combination vaccine is a live attenuated vaccine candidate being developed by the Beijing Institute of Biological Products (BJBPI). It is designed to provide simultaneous immunization against four viral diseases: measles, mumps, rubella, and varicella (chickenpox). By combining these four components into a single injection, the vaccine aims to reduce the number of required clinical visits and improve vaccination compliance in pediatric populations. The vaccine utilizes live attenuated strains of the Measles morbillivirus, Mumps orthorubulavirus, Rubella virus, and Human alphaherpesvirus 3 (Varicella-zoster virus) to elicit a protective immune response. It is currently in the preclinical stage of development.
- Other names
- MMRV vaccineMeasles-Mumps-Rubella-Varicella vaccineMMRV combination vaccine
02
Targets
Attenuated rubella virus antigens
Beyond the preview
Go deeper on measles, mumps, rubella and varicella vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles, mumps, rubella and varicella vaccine.